689 Shares in Cigna Group $CI Acquired by Calamos Wealth Management LLC

Calamos Wealth Management LLC acquired a new position in Cigna Group (NYSE:CIFree Report) in the second quarter, Holdings Channel reports. The firm acquired 689 shares of the health services provider’s stock, valued at approximately $228,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CI. Brighton Jones LLC boosted its stake in Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after purchasing an additional 318 shares during the period. GAMMA Investing LLC boosted its stake in Cigna Group by 79.0% in the 1st quarter. GAMMA Investing LLC now owns 5,394 shares of the health services provider’s stock worth $1,775,000 after purchasing an additional 2,381 shares during the period. CWA Asset Management Group LLC boosted its stake in Cigna Group by 17.8% in the 1st quarter. CWA Asset Management Group LLC now owns 932 shares of the health services provider’s stock worth $306,000 after purchasing an additional 141 shares during the period. Avior Wealth Management LLC boosted its stake in shares of Cigna Group by 2.9% during the 1st quarter. Avior Wealth Management LLC now owns 1,556 shares of the health services provider’s stock valued at $512,000 after buying an additional 44 shares during the period. Finally, Garde Capital Inc. acquired a new stake in shares of Cigna Group during the 1st quarter valued at $90,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analyst Ratings Changes

CI has been the subject of a number of research reports. The Goldman Sachs Group initiated coverage on shares of Cigna Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $370.00 target price for the company. TD Cowen raised shares of Cigna Group to a “strong-buy” rating in a research note on Monday, June 23rd. Guggenheim reissued a “buy” rating and set a $350.00 target price (down previously from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Weiss Ratings reissued a “hold (c+)” rating on shares of Cigna Group in a research note on Wednesday, October 8th. Finally, Wall Street Zen lowered shares of Cigna Group from a “buy” rating to a “hold” rating in a research note on Friday, October 3rd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $369.89.

Get Our Latest Research Report on CI

Insider Buying and Selling at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.70% of the company’s stock.

Cigna Group Stock Up 3.0%

Cigna Group stock opened at $299.81 on Monday. The company has a market capitalization of $80.03 billion, a P/E ratio of 16.37, a P/E/G ratio of 0.88 and a beta of 0.45. The firm’s fifty day simple moving average is $297.27 and its 200-day simple moving average is $307.91. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 1-year low of $256.89 and a 1-year high of $353.55.

Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. Cigna Group’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter last year, the firm earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were issued a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 2.0%. The ex-dividend date was Thursday, September 4th. Cigna Group’s dividend payout ratio (DPR) is 32.97%.

About Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.